NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/08/2022
Back to search
Official data from USPTO
MEDFOLIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
02/08/2022
Trademark type
Combined
Nice classes
20
Filing date
05/13/2009
Registration date
07/05/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/08/2022
Last transaction
02/08/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/01/2010
First use in commerce
11/01/2010
Drawing code
3
Owner type
16
Owner location
San Francisco, CA, US
Examiner
GAYNOR, BARBARA
Law office
M60
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the stylized wording "MEDFOLIO". The letter "L" in "FOLIO" is formed by a medication capsule.
Holders and representatives
Holders
MedFolio, LLC
MedFolio, LLC
Representatives
MedFolio, LLC
Technical classification
Nice Classes
Class 20
Vienna Codes
No Vienna codes available.
Goods and services
Class 20
Plastic medication cases sold empty containing a vibrating alarm as a reminder to take medication
Publications
History of USPTO decisions and trademark events.
47 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/08/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/08/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/08/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
08/31/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/05/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/19/2017
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/19/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/19/2017
ES8R
TEAS SECTION 8 RECEIVED
07/04/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/04/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/05/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
07/05/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/01/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/31/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/23/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
05/23/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/23/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
05/23/2011
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
05/23/2011
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/19/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/19/2011
ALIE
ASSIGNED TO LIE
05/05/2011
PAPER RECEIVED
04/28/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/29/2010
GNRT
NON-FINAL ACTION E-MAILED
11/29/2010
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/29/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/15/2010
IUAF
USE AMENDMENT FILED
11/12/2010
EISU
TEAS STATEMENT OF USE RECEIVED
11/12/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/29/2010
EX1G
SOU EXTENSION 1 GRANTED
05/28/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/28/2010
EXT1
SOU EXTENSION 1 FILED
05/11/2010
EEXT
SOU TEAS EXTENSION RECEIVED
05/11/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/15/2009
PUBO
PUBLISHED FOR OPPOSITION
09/22/2009
NPUB
NOTICE OF PUBLICATION
09/02/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/19/2009
ALIE
ASSIGNED TO LIE
08/18/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/12/2009
DOCK
ASSIGNED TO EXAMINER
08/12/2009
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
05/19/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/18/2009
NWAP
NEW APPLICATION ENTERED
05/16/2009
Continuous trademark protection
Get notified about every new filing that threatens MEDFOLIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.